Providence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary technology transfer of the shot, with a minimum production capacity of 600 million doses in 2022 and a target capacity of 1 billion doses.
Read More
Even though India has been grappling with the Covid -19 pandemic for more than a year now, its response to the myriad challenges including those pertaining to vaccine and vaccinations has left a lot to be desired
Read More
Amphotericin-B is used to treat Mucormycosis, also known as Black Fungus, which damages the nose, eyes, sinuses, and sometimes even the brain.
Read More
It said that the overall business confidence index has nosedived and stood at 51.5 in the current round after reporting a decadal high value of 74.2 in the previous survey round.
Read More
India has administered about 212 million doses, the most after China and the United States, but has given the necessary two doses to only about 3% of its 1.35 billion people.
Read More
According to a recent report from the Indian Institute of Technology (IIT) Delhi, Delhi needs to be ready for a third wave of the Covid-19 pandemic.
Read More
The stock gained 3.94 per cent to close at Rs 386.80 on the BSE. During the day, it jumped 4.99per cent to Rs 390.75.
Read More
The company is in the final stages of negotiations with the Food and Drug Administration of the US for conducting small-scale phase-III clinical trials of Covaxin in the United States
Read More
